InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
Recombinant monoclonal human IgG1 antibody against Spike RBD
InvivoGen
Recombinant monoclonal mouse IgG2a antibody against Spike RBD
InvivoGen
Recombinant monoclonal human IgG1NQ antibody against Spike RBD, non-glycosylated
InvivoGen
Recombinant monoclonal mouse IgG1e3 antibody against Spike RBD
InvivoGen
Recombinant monoclonal human IgA1 antibody against Spike RBD
